Citigroup Reiterates “Buy” Rating for Oxford Nanopore Technologies (LON:ONT)

Oxford Nanopore Technologies (LON:ONT)‘s stock had its “buy” rating reaffirmed by equities researchers at Citigroup in a research note issued on Friday, LSE.Co.UK reports. They presently have a GBX 210 ($2.66) target price on the stock. Citigroup’s price objective suggests a potential upside of 96.26% from the stock’s previous close.

Oxford Nanopore Technologies Stock Performance

Shares of LON:ONT opened at GBX 107 ($1.35) on Friday. Oxford Nanopore Technologies has a 12-month low of GBX 107 ($1.35) and a 12-month high of GBX 279 ($3.53). The company’s 50 day moving average price is GBX 135.31 and its two-hundred day moving average price is GBX 171.15. The firm has a market cap of £919.67 million, a PE ratio of -713.33 and a beta of 0.61. The company has a quick ratio of 6.01, a current ratio of 5.01 and a debt-to-equity ratio of 6.47.

Insiders Place Their Bets

In related news, insider Gurdial (Gordon) Sanghera acquired 39,196 shares of the company’s stock in a transaction on Wednesday, March 6th. The stock was purchased at an average cost of GBX 127 ($1.61) per share, with a total value of £49,778.92 ($63,003.32). Insiders have purchased a total of 39,421 shares of company stock worth $5,007,852 in the last 90 days. Company insiders own 30.06% of the company’s stock.

Oxford Nanopore Technologies Company Profile

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.